Scientific | Virtual
Event Title
Osteoporosis: A Perspective for 2024
May 16, 2024
- Date:
- May 16, 2024
- Time:
- 12:00 PM - 1:00 PM ET
- Organized By:
-
Organizer
![OWH Osteoporosis meeting](/https/www.fda.gov/files/styles/main_image_medium/public/owh_osteoporosisspeakerseries_1600x900_v1_option1_v2.jpg?itok=cczer7Yd)
In observance of National Women's Health Week (NWHW) 2024 and National Osteoporosis Awareness and Prevention month, the FDA Office of Women’s Health (OWH), hosted a free virtual public webinar titled: Osteoporosis: A perspective for 2024 presented by Marcella Donovan Walker, MD, MS.
Strong bones are essential to health and quality of life. Osteoporosis and fragility fractures are common and can be debilitating but there are steps that can be taken to help reduce the risk. Because osteoporosis is asymptomatic until the first clinical fracture, many women do not realize they are at risk. This lecture will summarize the current approach to assessing bone health, as well as preventing and treating osteoporosis with a focus on postmenopausal women.
The webinar offers continuing education (CME/CNE/CPE) credits and will be held virtually on the Zoom platform. Registrants will receive a link to attend the webinar after completing their registration. Live closed captioning will be available during the webinar. If you require additional accommodations, please request them when completing your registration.
For questions about this event please email [email protected].
Contact
- Office of Women's Health
- Food and Drug Administration
Office of Women's Health
10903 New Hampshire Ave WO32-2333
Silver Spring, MD 20993
- (301) 796-9440 Phone
- [email protected]